August 20, 2015 / 4:23 AM / 3 years ago

Valeant nears deal for "female Viagra" maker Sprout Pharmaceuticals - WSJ

Aug 20 (Reuters) - Canada’s Valeant Pharmaceuticals International Inc is nearing a deal to pay $1 billion for Sprout Pharmaceuticals, the company that just won approval to sell the first drug that aims to boost a woman’s libido, the Wall Street Journal reported.

Valeant would pay all cash, one $500 million installment upfront and one next year, for Sprout Pharmaceuticals and its pink libido pills that will be sold under the brand name Addyi, the Journal reported, citing a person familiar with the matter. (

Reuters could not immediately reach Valeant or Sprout for comment outside regular business hours. (Reporting by Supriya Kurane in Bengaluru; Editing by Anupama Dwivedi)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below